Tami Griffith
Family · Parachute, CONPI 1386683514
Payments from drug & device makers
Across 116 payments — averaging $18.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$743
- Amgen$196
- AstraZeneca$184
- GSK$157
- Pfizer$125
- Lilly USA, LLC$105
- plus $585 from 16 others
What the payments were for
- Food & beverage$2,094100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 45 | $743 |
| Amgen | 9 | $196 |
| AstraZeneca | 10 | $184 |
| GSK | 7 | $157 |
| Pfizer | 7 | $125 |
| Lilly USA, LLC | 7 | $105 |
| Novo Nordisk | 4 | $73 |
| Biohaven Pharmaceuticals, Inc. | 3 | $64 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $60 |
| Astellas Pharma US Inc | 2 | $50 |
| Johnson & Johnson | 3 | $47 |
| Boehringer Ingelheim | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Sanofi-aventis U.S. LLC | 2 | $37 |
| Eisai Inc. | 2 | $35 |
| Nestle Healthcare Nutrition Inc. | 2 | $27 |
| Merck | 1 | $22 |
| Dexcom, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Harmony Biosciences LLC | 1 | $16 |
| Exact Sciences | 1 | $14 |
| Genentech USA, Inc. | 1 | $12 |
How this compares
$2,094 in reported general payments places this provider in the 85th percentile of 2,182 family providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 11 | $26,702 |
| EliquisApixaban | 19 | $22,117 |
| JardianceEmpagliflozin | 17 | $16,728 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 23 | $16,399 |
| XareltoRivaroxaban | 17 | $16,328 |
| OzempicSemaglutide | 13 | $12,546 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $9,691 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $2,555 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 71 | $1,885 |
| Lidocaine | 16 | $1,766 |
| Gabapentin | 70 | $1,665 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 59 | $1,436 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 53 | $1,055 |
| Levothyroxine Sodium | 139 | $992 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 17 | $929 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Stiolto Respimat | $46 | $33,12640 claims |
| Lilly USA, LLCTrulicity, Humulin N | $105 | $27,56822 claims |
| PfizerEliquis | $125 | $22,11719 claims |
| Johnson & JohnsonXarelto | $47 | $16,32817 claims |
| Novo NordiskOzempic | $73 | $12,54613 claims |
| GSKTrelegy Ellipta | $157 | $9,69115 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,182 family providers in Colorado.
Other family in Parachute
- Laura GrahamLakewood$1.6M
- Corinne YoungColorado Springs$272K
- Margaret MachaffieColorado Springs$97K
- April RossGrand Junction$95K
- Jeannette LillerColorado Springs$74K
- Teal MeffordThornton$63K
- Jacquita JordanColorado Springs$52K
- Stephanie HanenbergColorado Springs$40K
- Courtney WeirFort Collins$30K
- Katie NadingDenver$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.